Get the Stockscreener App
1.3118
1.79%
-0.0282
Tilray Brands Inc stock is traded at $1.3118, with a volume of 24.43M.
It is down -1.79% in the last 24 hours and down -18.77% over the past month.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.
See More
Previous Close:
$1.34
Open:
$1.35
24h Volume:
24.43M
Relative Volume:
0.30
Market Cap:
$1.45B
Revenue:
$829.22M
Net Income/Loss:
$-248.96M
P/E Ratio:
-4.3727
EPS:
-0.3
Net Cash Flow:
$-92.10M
1W Performance:
-10.48%
1M Performance:
-18.77%
6M Performance:
+189.17%
1Y Performance:
-19.76%
1-Day Range:
$1.29
$1.35
1-Week Range:
$1.28
$1.47
52-Week Range:
$0.3507
$2.32
Tilray Brands Inc Stock (TLRY) Company Profile
Name
Tilray Brands Inc
Sector
Phone
519.322.8800
Address
655 MADISON AVENUE, NEW YORK
Compare TLRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
1.31 | 1.50B | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
144.33 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.43 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.39 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.51 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.53 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-05-24 | Reiterated | Alliance Global Partners | Neutral |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-29-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Mar-04-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-18-21 | Initiated | Barclays | Underweight |
| Nov-01-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-11-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-03-21 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| May-11-21 | Resumed | Cowen | Outperform |
| May-07-21 | Resumed | Jefferies | Buy |
| May-06-21 | Initiated | Canaccord Genuity | Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-18-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-18-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-01-20 | Reiterated | MKM Partners | Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| May-12-20 | Reiterated | The Benchmark Company | Buy |
| Apr-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Apr-09-20 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-13-20 | Initiated | BofA/Merrill | Neutral |
| Nov-13-19 | Reiterated | The Benchmark Company | Buy |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-22-19 | Reiterated | Piper Jaffray | Overweight |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Aug-14-19 | Reiterated | The Benchmark Company | Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Neutral |
| Jun-28-19 | Initiated | Consumer Edge Research | Overweight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Initiated | Oppenheimer | Perform |
| May-15-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-13-19 | Initiated | Alliance Global Partners | Neutral |
View All
Tilray Brands Inc Stock (TLRY) Latest News
Tilray Brands Has Been Buying Bitcoin. Could It Help the Stock Surge Higher? - Nasdaq
Can Tilray Brands Inc. stock deliver strong Q4 earningsChart Signals & Precise Entry and Exit Recommendations - newser.com
Heatmap analysis for Tilray Brands Inc. and competitorsQuarterly Growth Report & Stepwise Trade Signal Guides - newser.com
Why analysts recommend Tilray Brands Inc. (2HQ) stock2025 Technical Overview & High Accuracy Trade Alerts - newser.com
Trend Tracker for (TLRY) (TLRY:CA) - news.stocktradersdaily.com
How buyback programs support Tilray Brands Inc. (2HQ) stockJuly 2025 Setups & Accurate Trade Setup Notifications - newser.com
Should you wait for a breakout in Tilray Brands Inc.2025 Institutional Moves & Accurate Entry/Exit Alerts - newser.com
3 Stocks Under $10 We’re Skeptical Of - The Globe and Mail
What dividend safety score for Tilray Brands Inc. stockAnalyst Upgrade & High Accuracy Swing Trade Signals - newser.com
Applying Elliott Wave Theory to Tilray Brands Inc.Weekly Trade Summary & Weekly High Return Forecasts - newser.com
Sentiment analysis tools applied to Tilray Brands Inc.July 2025 Update & Verified Momentum Stock Watchlist - newser.com
Will Tilray Brands Inc. (2HQ) stock outperform value peers2025 Price Targets & Breakout Confirmation Trade Signals - newser.com
Is Tilray Brands Inc. stock supported by innovation pipelineJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
Cannabis Stocks To ConsiderOctober 31st - MarketBeat
Cannabis Stocks To Watch NowNovember 2nd - MarketBeat
Top Cannabis Stocks To ResearchOctober 29th - MarketBeat
Cannabis Stocks To Follow NowNovember 1st - MarketBeat
'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance - CNBC
Will Tilray Brands Inc. stock pay special dividends2025 Price Momentum & Target Return Focused Stock Picks - newser.com
Tilray Brands (NASDAQ:TLRY) Trading Up 3.9%Here's Why - MarketBeat
Tilray Medical forms partnership in Italy to broaden access to medical cannabis extracts - MSN
Tilray Surge: Is It a Good Time to Invest? - StocksToTrade
October Was a Tough Month for Cannabis Stocks - New Cannabis Ventures
What MACD signals say about Tilray Brands Inc.July 2025 Fed Impact & AI Powered Market Entry Strategies - newser.com
Will Tilray Brands Inc. see short term momentumFed Meeting & Technical Confirmation Alerts - newser.com
Tilray’s Financial Turnaround: From Deep Losses to First Quarterly Profit - AD HOC NEWS
How supply chain issues affect Tilray Brands Inc. stockWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com
Real time social sentiment graph for Tilray Brands Inc.Trade Volume Summary & Entry Point Strategy Guides - newser.com
Applying big data sentiment scoring on Tilray Brands Inc.2025 Price Targets & Low Risk Entry Point Tips - newser.com
Top Cannabis Stocks To Follow NowOctober 28th - MarketBeat
Tilray Brands (NASDAQ:TLRY) Trading Down 5.1%Here's Why - MarketBeat
Will Tilray Bounce Back Amid Challenges? - timothysykes.com
Tilray’s Turbulent Ride: What’s Next for Shareholders? - StocksToTrade
Cannabis Stocks To Follow TodayOctober 30th - MarketBeat
Tilray Brands Sets Sights on Asia: Bringing Award-Winning Craft Beers to Japan's Premier American Craft Beer Experience Festival - Investing News Network
Tilray Brands Inc Stock (TLRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tilray Brands Inc Stock (TLRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Merton Carl A | Chief Financial Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
970,279 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
742,069 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Buy |
0.58 |
6,000 |
3,496 |
698,287 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
874,564 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 30 '25 |
Option Exercise |
0.61 |
261,194 |
159,328 |
919,069 |
| Herhalt Johann Michael | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
239,930 |
| Looney Thomas P. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
354,416 |
| Hopkinson David G. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
335,563 |
| Clanachan David F | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
236,880 |
| Persofsky Renah | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
199,726 |
1.15%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):